NCT01015469

Brief Summary

Banded Versus Conventional Laparoscopic Roux-en-Y Gastric Bypass (GABY). The aim of this novel study is to evaluate, if an additional restrictive silastic ring can avoid dilation of the gastro-entero anastomosis and adjacent small bowel with consecutive better postoperative weight loss and significantly improved long-term weight maintenance. The study will not investigate the GaBP-Ring as medical product but the effect of the GaBP-Ring on weight loss in comparison to gastric bypass alone.

Trial Health

50
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
384

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started Feb 2009

Longer than P75 for phase_4

Geographic Reach
7 countries

14 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2009

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

November 17, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 18, 2009

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2014

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2015

Completed
Last Updated

February 17, 2011

Status Verified

February 1, 2011

Enrollment Period

5.1 years

First QC Date

November 17, 2009

Last Update Submit

February 16, 2011

Conditions

Keywords

bariatricsurgeryobesityRoux-en-Ygastricmedical devicebypassadiposityGaBP-RingBMIbandedlaparoscopic

Outcome Measures

Primary Outcomes (1)

  • postoperative reduction of body mass index (BMI) and maintenance related to used bariatric procedure

    0, 3, 6, 12 months and 2, 3, 4, 5 years

Study Arms (2)

Group A

ACTIVE COMPARATOR

Conventional laparoscopic Roux-en-Y gastric bypass (Golden Standard)

Procedure: Conventional laparoscopic Roux-en-Y gastric bypass

Group B

EXPERIMENTAL

Conventional laparoscopic Roux-en-Y gastric bypass with additional restrictive silastic ring

Procedure: conventional laparoscopic Roux-en-Y gastric bypass with additional restrictive silastic ring

Interventions

Conventional laparoscopic Roux-en-Y gastric bypass

Group A

conventional laparoscopic Roux-en-Y gastric bypass with additional restrictive silastic ring (GaBP-Ring)

Group B

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • BMI ≥ 40 kg /m2 to ≤ 50 kg/m2
  • Eating habit: sweet eater and volume eater
  • Signed informed consent
  • Patients with one or more of the following comorbidities: Hypertension, Diabetes mellitus Type 2, Hyperlipidemia, Hyperuricemia, Sleep apnea, Degenerative diseases of: Spine osteochondrosis, hip, knee, feet

You may not qualify if:

  • History of obesity surgery
  • History of major abdominal surgery with consecutive malabsorption (no resections of the stomach, small and large bowel (exception: appendectomy)
  • Patients not eligible to implement silastic ring size 6.5 cm
  • History of drug or alcohol abuse
  • History of major psychiatric illness conflicting with patient's compliance
  • History of recent or chronic steroid medication
  • Autoimmune disease
  • Inflammatory bowel disease or malabsorptive disease
  • Liver cirrhosis (CHILD B + C)
  • Active viral or bacterial disease (e.g. HIV, Hepatitis B or C, Tbc etc.)
  • Pregnant women or women with childbearing potential without efficient contraception
  • History of cancer in the last five years
  • Need of long-term anticoagulant medication for any reason
  • Any medication with ingredient ASA

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (14)

Hospital Hallein (Scientific Review Board)

Hallein, 5400, Austria

ACTIVE NOT RECRUITING

Hospital AZ St.-Jan AV

Bruges, 8000, Belgium

RECRUITING

AZ Sint-Blasius

Dendermonde, 9200, Belgium

RECRUITING

AZ Nikolaas

Sint-Niklaas, 9100, Belgium

RECRUITING

Privatpraxis Chirurgie bei Schlossparkklinik

Berlin, 14059, Germany

RECRUITING

Albert-Ludwigs-University

Freiburg im Breisgau, 79106, Germany

RECRUITING

Universitätsklinikum Hamburg-Eppendorf (UKE)

Hamburg, 20246, Germany

RECRUITING

Chirurgische Klinik München-Bogenhausen GmbH

München, 81679, Germany

RECRUITING

Schwarzwald-Baar Klinikum Villingen-Schwenningen GmbH

Villingen-Schwenningen, 78011, Germany

RECRUITING

Atruim Medical Centre

Heerlen, 6401, Netherlands

RECRUITING

Medical University of Lodz

Lodz, 90-152, Poland

RECRUITING

Centro Hospitalar de Lisboa Central

Lisbon, 1150-199, Portugal

RECRUITING

Hospital de Sao Sebastiano

Santa Maria de Feira, 4520-211, Portugal

RECRUITING

International Medical Center

Jeddah, 2172, Saudi Arabia

RECRUITING

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Konrad W Karcz, MD

    Albert-Ludwigs-University of Freiburg

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Burkhart Frankenberger

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

November 17, 2009

First Posted

November 18, 2009

Study Start

February 1, 2009

Primary Completion

March 1, 2014

Study Completion

March 1, 2015

Last Updated

February 17, 2011

Record last verified: 2011-02

Locations